SCHEMBL22263501

SCHEMBL22263501

COc1nc2ccccc2cc1C(C)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 1/20 0.47
PPARA Q07869 1/20 0.47
MAPT P10636 2/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
BTK Q06187 1/20 0.47
IKBKB O14920 1/20 0.46
KDM4E B2RXH2 6/20 0.45
ALDH1A1 P00352 5/20 0.45
GAA P10253 3/20 0.45
HDAC6 Q9UBN7 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HPGD P15428 2/20 0.44
TLR8 Q9NR97 1/20 0.44
CNR2 P34972 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CA12 O43570 1/20 0.41
CYP1A2 P05177 1/20 0.41
NT5E P21589 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423348 0.87 KDM4E (0.56) PPARDPPARAMAPTRAB9ASMN1; SMN2
SCHEMBL3715949 0.87 KDM4E (0.56) PPARDPPARAMAPTRAB9ASMN1; SMN2
SCHEMBL29934771 0.85 IKBKB (0.61) PPARDPPARAMAPTRAB9ASMN1; SMN2
SCHEMBL6603045 0.85 KDM4E (0.51) PPARDPPARAMAPTRAB9ASMN1; SMN2
SCHEMBL4432713 0.85 IKBKB (0.61) PPARDPPARAMAPTRAB9ASMN1; SMN2
SCHEMBL15671177 0.83 PPARD (0.45) PPARDPPARAMAPTRAB9ASMN1; SMN2
SCHEMBL15945346 0.83 SMN1; SMN2 (0.50) PPARDPPARAMAPTRAB9ASMN1; SMN2
SCHEMBL6604321 0.83 PPARD (0.45) PPARDPPARAMAPTRAB9ASMN1; SMN2
SCHEMBL15945345 0.82 MAPT (0.55) MAPTRAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL22278945 0.82 PPARA (0.53) PPARDPPARAMAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3719010-B1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD (CN) 2023-07-26 EP disclosed
EP-3719010-B1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD (CN) 2023-07-26 EP disclosed
US-11332457-B2 Aromatic compound, pharmaceutical composition and use thereof SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2022-05-17 US disclosed
US-11332457-B2 Aromatic compound, pharmaceutical composition and use thereof SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2022-05-17 US disclosed
US-11261170-B2 Aromatic compound, pharmaceutical composition and use thereof SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2022-03-01 US disclosed
CN-111148742-B Aromatic compound and pharmaceutical composition and application thereof 四川科伦博泰生物医药股份有限公司 2021-11-16 CN disclosed
EP-3719010-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2020-10-07 EP disclosed
EP-3719010-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2020-10-07 EP disclosed
US-20200277277-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2020-09-03 US disclosed
US-20200277277-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2020-09-03 US disclosed
US-20200239429-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2020-07-30 US disclosed
US-20200239429-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2020-07-30 US disclosed
CN-111148742-A Aromatic compound and pharmaceutical composition and application thereof 四川科伦博泰生物医药股份有限公司 2020-05-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11332457-B2 Aromatic compound, pharmaceutical composition and use thereof PPARD, PPARA, PPARG PPARD 1/4885PPARA 2/4885MAPT 862/4885
US-20200277277-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF PPARD, PPARA, PPARG PPARD 1/4885PPARA 2/4885MAPT 862/4885
US-11261170-B2 Aromatic compound, pharmaceutical composition and use thereof PPARD, PPARA, PPARG PPARD 1/4885PPARA 2/4885MAPT 862/4885
US-20200239429-A1 AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF PPARD, PPARA, PPARG PPARD 1/4885PPARA 2/4885MAPT 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.